Want to see VIR full AI Analyst Report?
Vir Biotechnology (VIR) Ownership Overview
10.08% Insiders
15.91% Mutual Funds
0.22% Other Institutional Investors
24.97% ETFs
48.83% Public Companies and Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 41.10% of the company’s stock is owned by Institutional Investors, 10.08% is owned by Insiders, and 48.83% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 18, 2025 | xxxxxxxxxxxxx | $37734 | |
Nov 04, 2025 | xxxxxxxxxxxxx | $7999 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $1161660 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,894,058 | Institution | 9.39% | 189,616,112 | |
| 13,808,730 | Institution | 8.16% | 164,738,149 | |
| 13,728,924 | Insider | 8.11% | 163,786,063 | |
| 11,718,725 | Institution | 6.93% | 139,804,389 | |
| 5,290,508 | Institution | 3.13% | 63,115,760 | |
| 2,631,204 | Institution | 1.55% | 31,390,264 | |
| 1,903,303 | Institution | 1.12% | 22,706,405 | |
| 1,676,204 | Institution | 0.99% | 19,997,114 | |
| 1,534,251 | Institution | 0.91% | 18,303,614 | |
| 1,520,209 | Institution | 0.90% | 18,136,093 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,718,725 | Institution | 6.93% | 139,804,389 | |
| 2,631,204 | Institution | 1.55% | 31,390,264 | |
| 1,676,204 | Institution | 0.99% | 19,997,114 | |
| 1,534,251 | Institution | 0.91% | 18,303,614 | |
| 1,520,209 | Institution | 0.90% | 18,136,093 | |
| 1,302,660 | Institution | 0.77% | 15,540,734 | |
| 720,000 | Institution | 0.43% | 8,589,600 | |
| 677,373 | Institution | 0.40% | 8,081,060 | |
| 559,885 | Institution | 0.33% | 6,679,428 | |
| 536,155 | Institution | 0.32% | 6,396,329 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,601,995 | Institution | 4.49% | 90,691,800 | |
| 4,872,331 | Institution | 2.88% | 54,472,661 | |
| 3,479,242 | Institution | 2.06% | 41,507,357 | |
| 3,429,637 | Institution | 2.03% | 38,343,342 | |
| 2,605,839 | Institution | 1.54% | 30,149,557 | |
| 1,909,131 | Institution | 1.13% | 21,344,085 | |
| 1,433,470 | Institution | 0.85% | 16,026,195 | |
| 1,285,571 | Institution | 0.76% | 15,336,862 | |
| 1,189,701 | Institution | 0.70% | 13,764,841 | |
| 1,154,375 | Institution | 0.68% | 13,356,119 |
FAQ
Who Owns Vir Biotechnology (VIR)?
According to the latest TipRanks data, approximately 0.22% of the company's stock is held by institutional investors, 10.08% is held by insiders, and 48.83% is held by retail investors.
What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.22% of Vir Biotechnology (VIR) stock is held by institutional investors.
What percentage of Vir Biotechnology (VIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 48.83% of Vir Biotechnology (VIR) stock is held by retail investors.
Who owns the most shares of Vir Biotechnology (VIR)?
iShares owns the most shares of Vir Biotechnology (VIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.